Back to search

Ireland· IE-PA-PA2059/083/001

Infutraze concentrate for solution for infusion

A elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente product containing copper chloride dihydrate + manganese chloride tetrahydrate + potassium iodide + sodium selenite anhydrous, registered in Ireland by Fresenius Kabi Deutschland GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC B05XA31

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedInfutraze concentrate for solution fo…ATCB05XA31REGISTER NO.IE-PA-PA2059/083/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente is registered in 11 of 19 countries.

Countries holding a registration under ATC B05XA31 (elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente · ATC B05XA31

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Copper chloride dihydrate + Manganese chloride tetrahydrate + Potassium iodide + Sodium selenite anhydrous
Manufacturer
Fresenius Kabi Deutschland GmbH
Country
Ireland (IE)
ATC code
B05XA31
ATC class
Elektrolyte, Kombinationen mit anderen Arzneistoffen, inkl. reine Spurenelemente
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA2059/083/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

102 interactions on record for elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente · interactions on record

102 records

  • 4 severe
  • 12 moderate
  • 86 minor

Most severe, free to view

  • RaltegravirJ05AJ01severe
  • ElvitegravirJ05AJ02severe
  • RaltegravirJ05AX08severe
  • ElvitegravirJ05AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0a146d20-a550-4250-b7c8-d9c92f3734c7
GET /v1/drugs/0a146d20-a550-4250-b7c8-d9c92f3734c7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate for solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "B05XA31"
  ],
  "strength": null,
  "pa_number": "PA2059/083/001",
  "substances": [
    "Copper chloride dihydrate",
    "Manganese chloride tetrahydrate",
    "Potassium iodide",
    "Sodium selenite anhydrous",
    "Zinc chloride"
  ],
  "legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "30/06/2023",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.